They reduce over-eating as efficiently as they reduce inflammation
doi: 10.1016/j.neuropharm.2025.110299 109 PfausJGShadiackAVan SoestTTseMMolinoffP
Some people require various forms, such as glutathione sublingual or IV, for better results
People with a BMI of 27 or higher may also qualify if they have a weight-related condition such as type 2 diabetes, sleep apnea, high blood pressure, or elevated cholesterol
You can start asking them here: | WeightWatchers
The NDA submission was partly based on topline results from the ongoing single location BHV4157-206-RWE study (NCT06529146), in which troriluzole 200 mg administered orally once daily led to a 5070% slower rate of decline from baseline in the functional Scale for the Assessment and Rating of Ataxia (f-SARA) in all SCA genotypes at 3 years compared to an external control arm. Data from the BHV4157-206 study (NCT03701399) also demonstrated disease stabilization in the SCA3 genotype and a reduction in falls in all SCA genotypes compared to placebo over 48 weeks. If approved, troriluzole will be the first and only medication indicated for the treatment of SCA
